首页> 外文OA文献 >Growth Factor-induced Phosphorylation of Sterol Regulatory Element-binding Proteins Inhibits Sumoylation, Thereby Stimulating the Expression of Their Target Genes, Low Density Lipoprotein Uptake, and Lipid Synthesis*S⃞
【2h】

Growth Factor-induced Phosphorylation of Sterol Regulatory Element-binding Proteins Inhibits Sumoylation, Thereby Stimulating the Expression of Their Target Genes, Low Density Lipoprotein Uptake, and Lipid Synthesis*S⃞

机译:生长因子诱导的甾醇调节元件结合蛋白的磷酸化抑制氨化,从而刺激其靶基因的表达,低密度脂蛋白的摄取和脂质合成* S Synthesis

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The destiny and activity of sterol regulatory element-binding proteins (SREBPs) in the nucleus are regulated by modification with ubiquitin, small ubiquitin-like modifier (SUMO), or phosphorus. ERK-dependent phosphorylation causes an increase in their transcriptional activity, whereas SUMO modification halts it. We hypothesized a causal linkage between phosphorylation and sumoylation because their sites are very closely located in SREBP-1 and -2 molecules. When Ser455, a phosphorylation site in SREBP-2, was substituted with Ala, this SREBP-2 mutant was more efficiently modified by SUMO-1. On the other hand, substitution of Asp inhibited SUMO conjugation, mimicking phosphoserine. When cells were cultured with insulin-like growth factor-1, sumoylation of SREBP-2 was decreased with an increase in its phosphorylation, but SREBP-2(S455A) was continuously sumoylated. An ERK cascade inhibitor, U0126, inversely augmented SUMO modification of SREBP-2. Insulin-like growth factor-1 treatment stimulated the expression of SREBP target genes such as the low density lipoprotein (LDL) receptor, squalene synthase, and hydroxymethylglutaryl-CoA synthase genes. These results indicate that growth factor-induced phosphorylation of SREBP-2 inhibits sumoylation, thereby facilitating SREBP transcriptional activity. Glutathione S-transferase pulldown assays revealed that wild-type SREBP-2, but not a mutant lacking Lys464, interacts with HDAC3 preferentially among the histone deacetylase family members. HDAC3 small interfering RNA induced gene expression of the LDL receptor and thereby augmented fluorescently labeled LDL uptake in HepG2 cells. In summary, growth factors inhibit sumoylation of SREBPs through their phosphorylation, thus avoiding the recruitment of an HDAC3 corepressor complex and stimulating the lipid uptake and synthesis required for cell growth.
机译:固醇调节元件结合蛋白(SREBPs)在细胞核中的命运和活性受泛素,小泛素样修饰剂(SUMO)或磷的修饰调控。 ERK依赖的磷酸化导致其转录活性增加,而SUMO修饰则将其终止。我们假设磷酸化和磺酰基化之间存在因果关系,因为它们的位点非常紧密地位于SREBP-1和-2分子中。当将SREBP-2中的一个磷酸化位点Ser455替换为Ala时,此SREBP-2突变体被SUMO-1更有效地修饰。另一方面,Asp的取代抑制了SUMO偶联,模仿了磷酸丝氨酸。当细胞用胰岛素样生长因子-1培养时,SREBP-2的磺酰化作用随其磷酸化的增加而降低,但SREBP-2(S455A)却被连续磺酰化。 ERK级联抑制剂U0126逆向增强SREBP-2的SUMO修饰。胰岛素样生长因子-1处理刺激了SREBP目标基因的表达,例如低密度脂蛋白(LDL)受体,角鲨烯合酶和羟甲基戊二酰辅酶A合酶基因。这些结果表明,生长因子诱导的SREBP-2的磷酸化抑制了SUMO化,从而促进了SREBP的转录活性。谷胱甘肽S-转移酶下拉试验表明,在组蛋白脱乙酰基酶家族成员中,野生型SREBP-2(而不是缺少Lys464的突变体)优先与HDAC3相互作用。 HDAC3小干扰RNA诱导LDL受体的基因表达,从而增加HepG2细胞中荧光标记的LDL的摄取。总之,生长因子通过SREBPs的磷酸化抑制SREBPs的磺酰化,从而避免了HDAC3 corepressor复合物的募集并刺激了细胞生长所需的脂质摄取和合成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号